A detailed history of Verition Fund Management LLC transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Verition Fund Management LLC holds 3,470 shares of BIO stock, worth $1.19 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,470
Previous 1,183 193.32%
Holding current value
$1.19 Million
Previous $323,000 259.13%
% of portfolio
0.01%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$263.97 - $344.64 $603,699 - $788,191
2,287 Added 193.32%
3,470 $1.16 Million
Q2 2024

Aug 14, 2024

SELL
$268.26 - $339.48 $283,014 - $358,151
-1,055 Reduced 47.14%
1,183 $323,000
Q1 2024

May 14, 2024

BUY
$304.11 - $351.99 $154,791 - $179,162
509 Added 29.44%
2,238 $774,000
Q4 2023

Feb 14, 2024

BUY
$269.37 - $365.04 $162,430 - $220,119
603 Added 53.55%
1,729 $558,000
Q3 2023

Nov 14, 2023

BUY
$350.25 - $422.63 $394,381 - $475,881
1,126 New
1,126 $403,000
Q3 2022

Nov 14, 2022

BUY
$412.59 - $563.26 $508,723 - $694,499
1,233 Added 138.38%
2,124 $886,000
Q2 2022

Aug 15, 2022

SELL
$463.67 - $597.16 $173,876 - $223,935
-375 Reduced 29.62%
891 $441,000
Q1 2022

May 13, 2022

BUY
$524.57 - $735.42 $133,765 - $187,532
255 Added 25.22%
1,266 $713,000
Q4 2021

Feb 14, 2022

BUY
$708.84 - $794.68 $716,637 - $803,421
1,011 New
1,011 $764,000
Q2 2021

Aug 16, 2021

SELL
$576.64 - $649.04 $269,290 - $303,101
-467 Closed
0 $0
Q1 2021

May 18, 2021

BUY
$547.01 - $662.35 $255,453 - $309,317
467 New
467 $266,000
Q4 2020

Feb 16, 2021

SELL
$510.68 - $643.45 $1.09 Million - $1.37 Million
-2,136 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$454.43 - $535.6 $493,510 - $581,661
1,086 Added 103.43%
2,136 $1.1 Million
Q2 2020

Aug 14, 2020

BUY
$334.87 - $493.06 $351,613 - $517,713
1,050 New
1,050 $474,000
Q1 2020

May 15, 2020

SELL
$320.01 - $409.07 $402,892 - $515,019
-1,259 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$319.73 - $374.2 $271,770 - $318,070
-850 Reduced 40.3%
1,259 $466,000
Q3 2019

Nov 14, 2019

SELL
$304.55 - $345.24 $19,491 - $22,095
-64 Reduced 2.95%
2,109 $702,000
Q2 2019

Aug 14, 2019

BUY
$286.93 - $312.59 $623,498 - $679,258
2,173 New
2,173 $679,000
Q1 2019

May 15, 2019

SELL
$224.3 - $317.41 $744,900 - $1.05 Million
-3,321 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$220.1 - $309.0 $353,040 - $495,636
1,604 Added 93.42%
3,321 $771,000
Q3 2018

Nov 15, 2018

SELL
$289.28 - $326.15 $1.64 Million - $1.85 Million
-5,670 Reduced 76.76%
1,717 $537,000
Q2 2018

Aug 15, 2018

BUY
$244.1 - $303.88 $591,210 - $735,997
2,422 Added 48.78%
7,387 $2.13 Million
Q1 2018

May 16, 2018

BUY
$233.97 - $274.11 $251,517 - $294,668
1,075 Added 27.63%
4,965 $1.24 Million
Q4 2017

Feb 15, 2018

BUY
$216.94 - $271.3 $353,178 - $441,676
1,628 Added 71.97%
3,890 $928,000
Q3 2017

Nov 14, 2017

BUY
$212.27 - $242.28 $480,154 - $548,037
2,262
2,262 $503,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.41B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.